ACRO BIOMEDICAL CO., LTD. (ACBM) Total liabilities 2017–2025
ACRO BIOMEDICAL CO., LTD. (ACBM) total liabilities at each fiscal year-end, per SEC filings.
$401,062FY2025 · since FY2017: $36,979 → $401,062
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $401,062 | +22.7% |
| FY2024 | $326,946 | +3.6% |
| FY2023 | $315,473 | +56.9% |
| FY2022 | $201,116 | +71.4% |
| FY2021 | $117,370 | -62.4% |
| FY2020 | $312,185 | +133.2% |
| FY2019 | $133,887 | -44.4% |
| FY2018 | $240,675 | +550.8% |
| FY2017 | $36,979 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACBM financial trends
ACBM RevenueACBM Net incomeACBM Net marginACBM Gross profitACBM Gross marginACBM Operating incomeACBM Operating marginACBM Operating cash flowACBM Free cash flowACBM Capital expendituresACBM Return on equityACBM Stock buybacksACBM Dividends paidACBM Total assetsACBM Shareholders’ equityACBM overview →